BR112015021769A2 - composições farmacêuticas compreendendo um agente ativo - Google Patents

composições farmacêuticas compreendendo um agente ativo

Info

Publication number
BR112015021769A2
BR112015021769A2 BR112015021769A BR112015021769A BR112015021769A2 BR 112015021769 A2 BR112015021769 A2 BR 112015021769A2 BR 112015021769 A BR112015021769 A BR 112015021769A BR 112015021769 A BR112015021769 A BR 112015021769A BR 112015021769 A2 BR112015021769 A2 BR 112015021769A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
active agent
gelatin capsules
soft gelatin
relates
Prior art date
Application number
BR112015021769A
Other languages
English (en)
Inventor
Cubel Suñé Núria
Original Assignee
Galenicum Health Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenicum Health Sl filed Critical Galenicum Health Sl
Publication of BR112015021769A2 publication Critical patent/BR112015021769A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo patente de invenção: "composições farmacêuticas compreendendo um agente ativo". a presente invenção refere-se a cápsulas de gelatina mole de liberação imediata compreendendo 17-beta-n-[2,5-bis(trifluorometil)]fenilcarbamoil-4-aza-5-alfa-androst-1-en-3-ona. a invenção adicionalmente se refere a processos para preparação de semelhantes cápsulas de gelatina mole.
BR112015021769A 2013-03-19 2014-03-18 composições farmacêuticas compreendendo um agente ativo BR112015021769A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13160044 2013-03-19
EP13194889 2013-11-28
PCT/EP2014/055455 WO2014147096A1 (en) 2013-03-19 2014-03-18 Pharmaceutical compositions comprising an active agent

Publications (1)

Publication Number Publication Date
BR112015021769A2 true BR112015021769A2 (pt) 2017-07-18

Family

ID=50349599

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015021769A BR112015021769A2 (pt) 2013-03-19 2014-03-18 composições farmacêuticas compreendendo um agente ativo

Country Status (6)

Country Link
US (1) US20160287524A1 (pt)
EP (1) EP2976068B1 (pt)
BR (1) BR112015021769A2 (pt)
ES (1) ES2692881T3 (pt)
RU (1) RU2015144543A (pt)
WO (1) WO2014147096A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2555485T1 (es) * 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
AU2017233134A1 (en) * 2016-03-16 2018-10-04 Hanmi Pharm. Co., Ltd. Dutasteride- and tamsulosin-containing hard capsule complex and preparation method therefor
JP2020055766A (ja) * 2018-10-01 2020-04-09 東洋カプセル株式会社 デュタステリドを含有する軟カプセル剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040105885A1 (en) * 2001-04-17 2004-06-03 Ping Gao Gelatin capsule exhibiting reduced cross-linking
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
AU2007308378B2 (en) * 2006-10-24 2013-02-21 Helsinn Healthcare S.A. Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
EP2395975A4 (en) * 2009-02-10 2013-05-22 Genepharm India Private Ltd ORAL PHARMACEUTICAL COMPOSITION OF DUTASTERIDE
US20130317117A1 (en) * 2010-11-24 2013-11-28 Pharmaceutics International, Inc. Self micro-emulsifying drug delivery system with increased bioavailability

Also Published As

Publication number Publication date
EP2976068A1 (en) 2016-01-27
EP2976068B1 (en) 2018-05-30
WO2014147096A1 (en) 2014-09-25
US20160287524A1 (en) 2016-10-06
RU2015144543A3 (pt) 2018-03-16
RU2015144543A (ru) 2017-04-27
ES2692881T3 (es) 2018-12-05

Similar Documents

Publication Publication Date Title
BR112016024631A2 (pt) cápsulas antimicrobianas para conectores médicos
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
CL2014002077A1 (es) Composicion farmaceutica que comprende fumarato de dimetilo; metodo de preparacion; capsula que comprende microtabletas de fumarato de dimetilo; metodo para el tratamiento, profilaxis o mejora de la esclerosis multiple.
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
EA201591805A1 (ru) Оксабицикло [2.2.2] кислоты - модуляторы gpr120
PH12015501096A1 (en) Composition for immediate and extended release
BR112013004016A2 (pt) formulações á base de nalbufina e as respectivas utilizações
BR112018011376A2 (pt) composição farmacêutica que compreende um inibi-dor de urat1 potente
CL2013000488A1 (es) Co-cristales de compuestos derivados de (2r)-5-oxo-1-(bencilpiperidin-4-il)-n-(piridin-2-il)pirrolidin-2-carboxamida y un agente de formacion de co-cristales; sales de los compuestos; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias e infecciosas.
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
PH12016500461A1 (en) Polyethylene glycol-containing composition
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
EA201990093A1 (ru) Двухкомпонентная композиция
BR112015021769A2 (pt) composições farmacêuticas compreendendo um agente ativo
EA201300079A2 (ru) Фармацевтическая композиция для пролонгированного высвобождения триметазидина
IN2014DN07897A (pt)
IN2013MU02442A (pt)
TN2015000058A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]